Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/08/2010CN101045745B Scale preparation method of bursin and application of used as avian influema vaccine adjuvant
12/08/2010CN101044239B Mammalian cell culture processes for protein production
12/08/2010CN100998872B Polypeptide medicine intercalation hydrotalcite and its preparation method
12/07/2010US7847156 Plants having improved growth characteristics and methods for making the same
12/07/2010US7847122 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time
12/07/2010US7847098 Fluorescent amino acid derivative and production method of the same
12/07/2010US7847090 Compositions and methods for siRNA inhibition of ICAM-1
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7847063 GLP-1 derivative
12/07/2010US7847062 vascular endothelial growth factor receptor (VEGFR)-binding polypeptides, comprising a fibronectin type III tenth (10Fn3) domain of 80 to 150 amino acids; Angiogenesis
12/07/2010US7847061 glucagon-like peptide 2 (GLP-2) such as teduglutide and other GLP-2 receptor agonists effective to improve intestinal function particularly in patients presenting with short bowel syndrome with colon-in-continuity
12/07/2010US7847060 TTK (TTK Protein kinase), URLC10 (cDNA for differentially expressed CO16 gene) and KOC1 (IGF II mRNA Binding Protein 3); for inducing antitumor immunity
12/07/2010US7847059 administering to the mammal a peptide that comprises 3 to 50 contiguous arginine amino acids or one with 100-200 contiguous lysine amino acids; treating onychomycosis (nail infection) caused by Trichophyton
12/07/2010US7847058 Method of modulating cell survival, differentiation and/or synaptic plasticity
12/07/2010US7846957 Aromatase inhibition to enhance assisted reproduction
12/07/2010US7846916 Steroid on carrier containing pressure sensitive adhesive
12/07/2010US7846913 Include insomnia, erectile dysfunction, female sexual dysfunction, neuropathic pain, attention deficit disorder, and depression; NMDA receptor agonists as a learning-enhancing secondary drug that improves the efficacy of a primary drug by locking in the psychological benefits derived from primary drugs
12/07/2010US7846911 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia
12/07/2010US7846907 Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
12/07/2010US7846902 formed from alanine, valine, leucine and isoleucine; improved nutrition, pharmacological effect and gustation, solubility and tableting property
12/07/2010US7846901 promotes regeneration of tissue, decreased apoptosis of stem cells
12/07/2010US7846900 derived from atrial natriuretic peptide prohormone; adenocarcinomas; side effect reduction
12/07/2010US7846899 decreasing white blood cell proliferation; by use of recombinant human CC10 (rhCC10), also known as recombinant human uteroglobin
12/07/2010US7846898 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
12/07/2010US7846897 inhibiting binding between N-methyl-D-aspartate receptors and neuronal proteins; tat internalization peptide; stroke therapy
12/07/2010US7846896 PEG conjugates of NK4
12/07/2010US7846895 Selectively/specifically targeted antimicrobial peptide (STAMP) which comprises a targeting peptide and an antimicrobial peptide; "targeted" antibiotic therapies to combat mucosal pathogens with a minimal impact on normal microflora; e.g. peptide G10KHc and a protease inhibitor and/or rhDNase
12/07/2010US7846894 comprising a Cricetulus griseus ( FAIM, FADD, PDCD6 and Requiem) sequence capable of mediating apoptosis of cells
12/07/2010US7846893 Drug-polymer conjugates coupled to a peptidic carrier
12/07/2010US7846892 phage-display single chain antibody libraries and screening against amyloid-beta protein, peptide; fusion proteins; kits
12/07/2010US7846891 introducing a precursor comprising amphiphilic self-assembling peptides (SAPs), also referred to as sapeptides, into the subject at or in the vicinity of the site of injury; a regeneration promoting factor (nerve growth factor), siRNA; permissive for regeneration of neural tissue and allows axon growth
12/07/2010US7846730 Inhibitors; hybridizing 3'-untranslated region of nucleic acid molecule; controlling apoptosis
12/07/2010US7846679 Methods for detecting the presence of mutant mammalian presenilin protein
12/07/2010US7846652 Using kinase activation/phosphorylation as diagnostic indication of receptor modulation; for treatment of cell proliferative and inflammatory disorders
12/07/2010US7846651 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
12/07/2010US7846487 A neutraceutical comprising a dehydrated product of Type II collagen that retains its original natural structure and biological activity, sodium or potassium chloride and water; nonhydrolyzing; storage stability; antiarthritic agents;tablets; capsules; cream; lotion; biodrug; food supplements
12/07/2010US7846483 Cosmetic composition for skin application suitable for relaxing expression wrinkles
12/07/2010US7846474 Administering a bisphosphonate until the bone mineral density is within a normal range, interrupting administration to enable the development of the sectional momentum of inertia, and resuming administration when the bone mineral density falls by 5-10% of the normal range
12/07/2010US7846468 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/07/2010US7846457 Cosmetic use of botulinum toxin for the treatment of eyebrow and forehead ptosis, and unwanted eyebrow expression
12/07/2010US7846456 treating a mammary gland disorder, including hyperplastic, hypertonic, cystic and/or neoplastic mammary gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted breast tissue
12/07/2010US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3
12/07/2010US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection
12/07/2010US7846450 Glycoprotein-100 peptide for use as tool in treatment and diagnosis of cancer and viral infection
12/07/2010US7846448 Lolium perenne (Lol p 1) polypeptide for use as diagnostic/prognostic indicator or allergic reactions
12/07/2010US7846442 Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
12/07/2010US7846441 Treatment with anti-ErbB2 antibodies
12/07/2010US7846438 Methods of promoting neurite outgrowth with soluble TAJ polypeptides
12/07/2010US7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same
12/07/2010US7846433 Methods of treating pre-eclampsia and eclampsia
12/07/2010US7846431 Composition comprising hyaluronidase glycoprotein that is active at neutral pH and contains at least one sugar moiety that is covalently attached to an asparagine for use in treatment of diabetic disorders
12/07/2010US7846430 Using lysozme as viracidal agent in treatment and prevention of cell proliferative diseases
12/07/2010US7846429 Compositions and methods for elimination of unwanted cells
12/07/2010US7846427 Stabilized interferon liquid formulations
12/07/2010CA2560221C Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
12/07/2010CA2542104C Method for the identification of epitopes related to immunogenicity in biopharmaceuticals
12/07/2010CA2514816C Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
12/07/2010CA2472309C Multiple dose aromatase inhibitor for treating infertility
12/07/2010CA2440111C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2398335C Herpes virus strains
12/07/2010CA2390215C Phaseolamin compositions and methods for using the same
12/07/2010CA2287505C Inhibitors of cellulolytic, xylanolytic and .beta.-glucanolytic enzymes
12/07/2010CA2262406C Gene therapy for congestive heart failure
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138955A2 Methods and compositions for treating neoplasia
12/02/2010WO2010138889A1 Peptides for the treatment of hcv infections
12/02/2010WO2010138839A2 Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/02/2010WO2010138794A2 Regulation of sodium channels by plunc proteins
12/02/2010WO2010138740A1 Inhibition 0f inflammation using antagonists of muc1
12/02/2010WO2010138671A1 Glp-1 receptor agonist compounds for sleep enhancement
12/02/2010WO2010138637A2 Fibromodulin peptide
12/02/2010WO2010138631A1 Compositions and methods for production of aglycosylated plasminogen
12/02/2010WO2010138423A1 Cyclosporin derivatives for treating inflammatory diseases and conditions
12/02/2010WO2010138422A1 Cyclosporin derivatives for enhancing the growth of hair
12/02/2010WO2010138397A1 Caveolin 1-reporter protein knock-in mouse
12/02/2010WO2010138389A2 Methods of treating urogenital-neurological disorders using neurotrophin retargeted endopepidases
12/02/2010WO2010138384A2 Methods of treating urogenital-neurological disorders using interleukin retargeted endopeptidases
12/02/2010WO2010138382A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
12/02/2010WO2010138343A1 Neuromedin u receptor agonists
12/02/2010WO2010138180A2 Compositions and methods for cardiac tissue repair
12/02/2010WO2010138173A1 Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans
12/02/2010WO2010138002A1 Methods for producing neuronal cells and uses thereof
12/02/2010WO2010137594A1 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
12/02/2010WO2010137547A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
12/02/2010WO2010137022A1 Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
12/02/2010WO2010137021A2 Method of generating connective tissue
12/02/2010WO2010137012A1 Peptide therapy for amphiregulin mediated diseases
12/02/2010WO2010136897A2 Expression of recombinant proteins
12/02/2010WO2010136896A1 Assays for influenza virus hemagglutinins
12/02/2010WO2010136877A1 Muteins of the pyrroline-5-carboxylate reductase 1
12/02/2010WO2010136841A2 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
12/02/2010WO2010136831A1 Novel peptides, process for preparation thereof, and use thereof
12/02/2010WO2010136622A1 Use of rgs-14 protein in order to produce a memory enhancer
12/02/2010WO2010136621A1 Use of rgs-14 protein in order to produce a drug for the treatment or prevention of cognitive and memory disorders
12/02/2010WO2010136617A1 Polymeric conjugate for treating bacterial infections
12/02/2010WO2010136589A1 Treatment of tissue adhesion
12/02/2010WO2010136562A2 Moraxella catarrhalis antigens
12/02/2010WO2010136548A2 Fibrosuppressant biotherapeutics
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 3163